Trial Profile
A prospective randomized study of adjuvant chemotherapy with navelbine [vinorelbine] and cisplatin in completely resected non small cell lung cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Sep 2009
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms ANITA-01
- Sponsors Pierre Fabre
- 31 Jul 2009 Preliminary BRAC1 analyses have been presented at the 13th World Conference on Lung Cancer.
- 31 Oct 2006 New trial record.